000 | 01168 a2200325 4500 | ||
---|---|---|---|
005 | 20250517083108.0 | ||
264 | 0 | _c20171018 | |
008 | 201710s 0 0 eng d | ||
022 | _a1179-1926 | ||
024 | 7 |
_a10.1007/s40262-016-0371-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGabriel, Laurence | |
245 | 0 | 0 |
_aQuantitative Prediction of Drug Interactions Caused by CYP1A2 Inhibitors and Inducers. _h[electronic resource] |
260 |
_bClinical pharmacokinetics _c08 2016 |
||
300 |
_a977-90 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 |
_aCytochrome P-450 CYP1A2 _xmetabolism |
650 | 0 | 4 |
_aCytochrome P-450 CYP1A2 Inhibitors _xpharmacology |
650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xmetabolism |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 | _aSmoking |
700 | 1 | _aTod, Michel | |
700 | 1 | _aGoutelle, Sylvain | |
773 | 0 |
_tClinical pharmacokinetics _gvol. 55 _gno. 8 _gp. 977-90 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40262-016-0371-x _zAvailable from publisher's website |
999 |
_c25789607 _d25789607 |